prednisolone has been researched along with Choroidal Detachment in 3 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Choroidal Detachment: Separation of the CHOROID from the SCLERA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study we compared the anatomic and functional outcomes of two steroid treatments on rhegmatogenous retinal detachment (RRD) combined with choroidal detachment (CD), namely treatment with oral prednisolone (1 mg/kg daily) for 3-7 days before vitrectomy or a single periocular injection of methylprednisolone (40 mg) 1-3 days before vitrectomy." | 9.30 | The effect of single periocular injection of methylprednisolone and drainage of suprachoroidal fluid in the treatment of rhegmatogenous retinal detachment combined with choroidal detachment. ( Chen, H; Chen, X; Wang, X; Wei, Y; Zhou, R, 2019) |
| "In this study we compared the anatomic and functional outcomes of two steroid treatments on rhegmatogenous retinal detachment (RRD) combined with choroidal detachment (CD), namely treatment with oral prednisolone (1 mg/kg daily) for 3-7 days before vitrectomy or a single periocular injection of methylprednisolone (40 mg) 1-3 days before vitrectomy." | 5.30 | The effect of single periocular injection of methylprednisolone and drainage of suprachoroidal fluid in the treatment of rhegmatogenous retinal detachment combined with choroidal detachment. ( Chen, H; Chen, X; Wang, X; Wei, Y; Zhou, R, 2019) |
| " The first 125 mg of methylprednisolone (mPSL) for 3 days was intravenous, after which it was switched to oral prednisolone (PSL) therapy and the dosage was gradually reduced." | 1.72 | Posterior scleritis with choroidal detachments and periaortitis associated with IgG4-related disease: A case report. ( Kadoya, M; Koizumi, K; Kondo, M; Kubo, A; Mase, Y; Masuda, K; Matsumoto, A; Sotozono, C, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Mase, Y | 1 |
| Kubo, A | 1 |
| Matsumoto, A | 1 |
| Masuda, K | 1 |
| Kadoya, M | 1 |
| Koizumi, K | 1 |
| Sotozono, C | 1 |
| Kondo, M | 1 |
| Edwards, RG | 1 |
| Vanderhoof, S | 1 |
| Palestine, A | 1 |
| Seibold, LK | 1 |
| Wei, Y | 1 |
| Zhou, R | 1 |
| Wang, X | 1 |
| Chen, X | 1 |
| Chen, H | 1 |
1 review available for prednisolone and Choroidal Detachment
| Article | Year |
|---|---|
Bilateral Secondary Angle Closure During Daratumumab Infusion: A Case Report and Review of the Literature.
Topics: Administration, Ophthalmic; Amyloidosis; Antibodies, Monoclonal; Antineoplastic Agents; Choroidal Ef | 2020 |
1 trial available for prednisolone and Choroidal Detachment
| Article | Year |
|---|---|
The effect of single periocular injection of methylprednisolone and drainage of suprachoroidal fluid in the treatment of rhegmatogenous retinal detachment combined with choroidal detachment.
Topics: Administration, Oral; Adult; Aged; Choroid Diseases; Choroidal Effusions; Combined Modality Therapy; | 2019 |
1 other study available for prednisolone and Choroidal Detachment
| Article | Year |
|---|---|
Posterior scleritis with choroidal detachments and periaortitis associated with IgG4-related disease: A case report.
Topics: Aged; Choroidal Effusions; Humans; Immunoglobulin G; Immunoglobulin G4-Related Disease; Male; Predni | 2022 |